Position
Parallel Advisors, LLC in Madrigal Pharmaceuticals, Inc.
Back to the book · All holders of MDGL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$14.8K$582.34 → $523.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 251 | $146.2K | — | — | — | 0.0% |
| Q1 2026 | 258 | $135.1K | $523.47 | −$14.8K | $3.66K | 0.0% |